SCHEMBL24988528

SCHEMBL24988528

CNCCc1ccc2c(c1)OCS2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
TSHR P16473 2/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
THPO P40225 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM4E B2RXH2 2/20 0.42
GMNN O75496 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
BLM P54132 1/20 0.42
GFER P55789 1/20 0.42
PMP22 Q01453 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24988188 0.88 MAPT (0.44) MAPTTSHRMAPK1TP53CYP1A2
SCHEMBL31143752 0.82 CNR1 (0.38) ALDH1A1TAAR1
SCHEMBL25371172 0.79 TAAR1 (0.54) MAPTMAPK1TP53CYP1A2ALOX15
SCHEMBL26055709 0.79 KDM4E (0.36) MAPTTSHRMAPK1KDM4ESMN1; SMN2
SCHEMBL14612463 0.78 CTSL (0.39) MAPTMAPK1CYP1A2ALDH1A1LMNA
SCHEMBL24988630 0.76 TAAR1 (0.60) TAAR1SIGMAR1
SCHEMBL24988629 0.76 TAAR1 (0.60) TAAR1SIGMAR1
SCHEMBL24988526 0.76 TAAR1 (0.60) TAAR1SIGMAR1
SCHEMBL31143688 0.74 CTSL (0.32)
Homarylamine SCHEMBL29412731 0.73 TAAR1 (0.61) TSHRMAPK1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023156453-A1 PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE CYBIN IRL LIMITED (IE) 2023-08-24 WO disclosed
WO-2023288013-A2 NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS MYDECINE INNOVATIONS GROUP INC. (US) 2023-01-19 WO disclosed